Vancouver, Canada: The adMare Academy is pleased to announce the latest Canadian life science leaders accepted into its Executive Institute — a one-of-a-kind national executive development program custom designed to ensure that the Canadian life sciences sector has the management talent it needs to lead the world.

Launched last year with the support of Pfizer Canada, the Institute has been widely heralded by participants, as well as throughout the industry nationally. With applications more than doubling for year two, the program Adjudication Committee has selected 19 executives, 10 women and 9 men, who have demonstrated impressive experience, accomplishment, and impact; and who span the Canadian industry from sea to sea (and even stretch south to the Bay Area, attracting a Canadian working at one of the world’s top biotech firms). These successful applicants to the 2019-2020 adMare Academy Executive Institute are:

  • Arun Anand, Chief Executive Officer and Co-founder, Tieös Pharmaceuticals, Richmond Hill, ON
  • Nadine Beauger, Chief Executive Officer, IRICoR, Montréal, QC
  • Veronique Bougie, Acting Chief Executive Officer, Mperia Therapeutics, Westmount, QC
  • Lee Bowman, Chief Operating Officer, Mediphage Bioceuticals, Toronto, ON
  • Brian Canestraro, General Manager, Intercept Pharmaceuticals, Mississauga, ON
  • Charles Cuerrier, Chief Executive Officer and Co-founder, Spiderwort, Ottawa, ON
  • Jason Ding, Managing Director, National Life Sciences & Healthcare CF Leader, Deloitte, Edmonton, AB
  • Monica Gautam, Managing Director, COMPASS Medical Affairs Consulting, Georgetown, ON
  • Sabrina Leslie, Founder, Chief Scientific Officer and President, ScopeSys, Montréal, QC
  • Sharon Louis, Vice President, Research & Development, STEMCELL Technologies, Vancouver, BC
  • Francois-Thomas Michaud, Chief Executive Officer, Feldan Therapeutics, Quebec, QC
  • Mark Mitchell, Associate Director, US Medical Affairs Finance, Genentech, South San Francisco, CA
  • Jennifer Moody, Sr. Director, Research Operations, Bluerock Therapeutics, Toronto, ON
  • Mehrsa Raeiszadeh, Chief Operating Officer, Novateur Ventures, North Vancouver, BC
  • Lucas Siow, Chief Executive Officer and Co-Founder, ProteinQure, Toronto, ON
  • Anne Stevens, Chief Operating Officer and Director, Aequus Pharmaceuticals, Vancouver, BC
  • Mary Sunderland, Field Medical Lead, Ocular Gene Therapy, Novartis, Toronto, ON
  • Catalina Vasquez, Chief Operating Officer, Nanostics, Edmonton, AB
  • James Wang, President and Founder, KDM Laboratories, St. Laurent, QC

“Following a remarkable success with the inaugural year of the adMare Executive Institute, it brings us great pride to continue the journey we started last year with Pfizer Canada, equipping our life sciences leaders with the unique skills required to create and manage global anchor companies here in Canada,” said Gordon C. McCauley, President and CEO of adMare BioInnovations. “It is rewarding to see the first cohort graduate as stronger leaders, already applying the learnings of the program towards the growth of their companies and committed to continuing their engagement with the academy as alumni. We are delighted to now build on their success and welcome the 2019-2020 participants.”

“Since 2017 we have been proud to sponsor the Executive Institute and adMare BioInnovations to meet the development needs expressed by life sciences industry stakeholders across Canada,” said John Helou, President, Pfizer Canada. “We are overwhelmed by the positive response received to date.”

The adMare Executive Institute curriculum is delivered in collaboration with the not-for-profit Center for Creative Leadership (CCL), ranked among the world’s Top 5 institutions for executive education. The program combines researched and proven best practices/principles with targeted industry topics to take participants on a leadership journey. The Executive Institute participants will convene in Montreal for their first face-to-face session on
September 23rd with additional workshops to be held in Toronto and Vancouver throughout 2019 until April
2020.

About adMare BioInnovations:
adMare BioInnovations is a pan-Canadian enterprise with global reach, changing the landscape of the Canadian life sciences ecosystem. We do this by sourcing the most therapeutically and commercially promising research from leading academic and biotech partners to create new companies of scale, providing specialized expertise and infrastructure to help existing companies scale up, and driving the growth of those companies into Canadian anchors by training the next generation of highly-qualified personnel. www.admarebio.com

About the adMare Academy:
The adMare Academy was created to deliver on a critical part of the organization’s mission: To uniquely train the next generation of highly-qualified personnel to drive the development of innovation. The Academy currently encompasses three distinct streams: The Executive Institute, the Post-Graduate Institute and the Undergraduate Institute. Each provides a customized training program to ensure that the Canadian life sciences sector has the scientific and management talent to lead the world. The Academy is firmly committed to addressing issues of gender disparity, and to supporting diversity in the Canadian life sciences sector.

For additional information, please contact:
Julia White
Senior Manager, Communications, adMare BioInnovations
Direct: 604.827.1226
Email: jwhite@admarebio.com